Medicine · 2025
Pre-endoscopy drink of small doses of simethicone and pronase solution improves visualization in upper gastrointestinal endoscopy: Randomised double-blind experiment.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Yuan, Jiang Jingping, Sheng Jinyi, Wu Junmin
Аннотация
BACKGROUND: Upper gastrointestinal endoscopy (UGE) was the gold standard investigative modality for gastrointestinal diseases. High quality of visualization was essential to high-quality UGE. Our aim was to compare the effect of the small doses of simethicone plus pronase in improving visibility during UGE.
METHODS: Four hundred patients underwent UGE and were divided into 4 groups randomly. All patients took medicine 15 to 30 minutes before the examination. The premedication in the group D was dyclonine. The other 3 groups were administered simethicone (group S), pronase solution (group P) alone, and simethicone plus pronase solution (group P + S). The mucosal visibility score and total mucosal visibility score (TMVS) were recorded. The lower the score, the cleaner the gastric mucosa. Adverse events were also recorded.
RESULTS: We studied the UGE pictures of 400 patients. The group P + S had a significantly better TMVS than the other groups (4.91 ± 0.99 in group P + S vs 6.76 ± 1.58 in group D, P < .05; 4.91 ± 0.99 in group P + S vs 5.61 ± 0.91 in group S, P < .05; 4.91 ± 0.99 in group P + S vs 6.46 ± 0.82 in group P, P < 0. 05). However, there was no significant differences were found between group D versus group P on TMVS.
CONCLUSION: The application of small doses of simethicone and pronase solution can create good mucosal and has no side effects.
METHODS: Four hundred patients underwent UGE and were divided into 4 groups randomly. All patients took medicine 15 to 30 minutes before the examination. The premedication in the group D was dyclonine. The other 3 groups were administered simethicone (group S), pronase solution (group P) alone, and simethicone plus pronase solution (group P + S). The mucosal visibility score and total mucosal visibility score (TMVS) were recorded. The lower the score, the cleaner the gastric mucosa. Adverse events were also recorded.
RESULTS: We studied the UGE pictures of 400 patients. The group P + S had a significantly better TMVS than the other groups (4.91 ± 0.99 in group P + S vs 6.76 ± 1.58 in group D, P < .05; 4.91 ± 0.99 in group P + S vs 5.61 ± 0.91 in group S, P < .05; 4.91 ± 0.99 in group P + S vs 6.46 ± 0.82 in group P, P < 0. 05). However, there was no significant differences were found between group D versus group P on TMVS.
CONCLUSION: The application of small doses of simethicone and pronase solution can create good mucosal and has no side effects.